Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair.

One of the immediate sequelae of bone fracture is regional hypoxia resulting from vasculature disruption. Hypoxia stabilizes and activates the transcription factor hypoxia inducible factor-1alpha (HIF-1alpha), which ultimately leads to HIF-1-regulated gene expression. Because nothing is known about HIF-1 involvement in bone regeneration, we performed a series of experiments to elucidate the expression pattern of HIF-1alpha and selected HIF-1 target genes using a rat femoral fracture model. Callus samples were obtained on postfracture days (PFD) 3, 5, 7, 10, 14, and 21. Quantitative RT-PCR (qRT-PCR) was employed to quantify the temporal mRNA expression patterns of HIF-1alpha, vascular endothelial growth factor (VEGF), inducible nitric oxide synthase (iNOS), and heme oxygenase-1 (HO-1). Elevated HIF-1alpha and VEGF expression was seen at all time points, with peak increases of approximately 6- and 2-fold relative to the intact bone present on PFD 10 for HIF-1alpha and VEGF, respectively. Robust activation of iNOS was detected solely on PFD 10 (6.8-fold) with all other time points showing slight downregulation. HO-1 expression peaked on PFD 3 (4.5-fold) with no significant changes on any other PFD. Western blot analysis verified the temporal expression patterns with HIF-1alpha protein expression showing a steady rise to a PFD 10 peak of approximately 18-fold. Similarly, the expression patterns for VEGF and HO-1 showed increases of approximately 4-fold at their PFD 10 and PFD 3 peaks, respectively. Immunohistochemical analysis of PFD 10 callus sections revealed coexpression of HIF-1alpha and VEGF in proliferating chondrocytes and active osteoblasts. Immunostaining for HO-1 on PFD 3 callus sections demonstrated strong expression in hematoma macrophages and vascular endothelial cells. Taken together, these experiments demonstrate for the first time that HIF-1alpha is upregulated at both transcriptional and translational levels in the fracture callus and indicate that PFD 10 may be a key angiogenic time point in the developing rat fracture callus.

[1]  Hong-Hee Kim,et al.  Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. , 2002, Cytokine.

[2]  Min Wang,et al.  Nitric Oxide Modulates Fracture Healing , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  T. Einhorn,et al.  Production of a standard closed fracture in laboratory animal bone , 1984, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[4]  R K Jain,et al.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Murrell,et al.  Localization of Nitric Oxide Synthases During Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[7]  Jill A. Helms,et al.  Altered fracture repair in the absence of MMP9 , 2003, Development.

[8]  Hongshik Ahn,et al.  Transcriptional Profiling of Bone Regeneration , 2002, The Journal of Biological Chemistry.

[9]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Thomas A Einhorn,et al.  Fracture healing as a post‐natal developmental process: Molecular, spatial, and temporal aspects of its regulation , 2003, Journal of cellular biochemistry.

[11]  Y. Vodovotz,et al.  Nitric oxide and wound repair: role of cytokines? , 2002, Nitric oxide : biology and chemistry.

[12]  C. Brighton,et al.  Oxygen tension of healing fractures in the rabbit. , 1972, The Journal of bone and joint surgery. American volume.

[13]  H. Esumi,et al.  Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. , 2003, Acta biochimica Polonica.

[14]  G. Semenza,et al.  Hypoxia-inducible Factor-1 Mediates Transcriptional Activation of the Heme Oxygenase-1 Gene in Response to Hypoxia* , 1997, The Journal of Biological Chemistry.

[15]  M. Longaker,et al.  VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. , 2000, American journal of physiology. Cell physiology.

[16]  Timo Jämsä,et al.  Adenoviral VEGF‐A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues , 2003, The journal of gene medicine.

[17]  T Kobayashi,et al.  Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. , 2001, Genes & development.

[18]  J. Hibbs,et al.  Nitric oxide: a cytotoxic activated macrophage effector molecule. , 1988, Biochemical and biophysical research communications.

[19]  A. Sica,et al.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter , 1995, The Journal of experimental medicine.

[20]  H. Spiegel,et al.  Cellular mechanisms of bone repair. , 1997, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[21]  H. Redmond,et al.  Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Napoleone Ferrara,et al.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation , 1999, Nature Medicine.

[23]  C. Rubin,et al.  Cloning of a novel cDNA expressed during the early stages of fracture healing. , 1998, Biochemical and biophysical research communications.

[24]  C. Brighton,et al.  Early histological and ultrastructural changes in medullary fracture callus. , 1991, The Journal of bone and joint surgery. American volume.

[25]  H. Frost,et al.  The biology of fracture healing. An overview for clinicians. Part I. , 1989, Clinical orthopaedics and related research.

[26]  R. Johnson,et al.  HIF-1α controls extracellular matrix synthesis by epiphyseal chondrocytes , 2003, Journal of Cell Science.

[27]  D. Madison,et al.  NITRIC OXIDE AND , 1994 .

[28]  C. Koch,et al.  Adaptation of chondrocytes to low oxygen tension: Relationship between hypoxia and cellular metabolism , 1996, Journal of cellular physiology.

[29]  T. Clemens,et al.  Selected Contribution: Osteocytes upregulate HIF-1alpha in response to acute disuse and oxygen deprivation. , 2001, Journal of applied physiology.

[30]  M. Hadjiargyrou,et al.  The E11 osteoblastic lineage marker is differentially expressed during fracture healing. , 2001, Bone.

[31]  J. Cooke,et al.  Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. , 2001, Cardiovascular research.

[32]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[33]  F. Bach,et al.  Heme oxygenase-1: unleashing the protective properties of heme. , 2003, Trends in immunology.

[34]  G. Semenza Hypoxia-inducible factor 1: master regulator of O2 homeostasis. , 1998, Current opinion in genetics & development.

[35]  C. Rubin,et al.  Temporal Expression of the Chondrogenic and Angiogenic Growth Factor CYR61 During Fracture Repair , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  A. Choi,et al.  Heme oxygenase-1: the "emerging molecule" has arrived. , 2002, American journal of respiratory cell and molecular biology.

[37]  M. Longaker,et al.  Hypoxia Regulates VEGF Expression and Cellular Proliferation by Osteoblasts in Vitro , 1999 .